Cargando…

Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition

SIMPLE SUMMARY: Here, we demonstrate for the first time that ECM composition cooperates with CAFs to jointly regulate/modulate the highly dynamic interactions between the CPC and CSC cell lines and establish a continuum between tumor initiation and progression in primary PDAC tumors. Altogether, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannone, Stefania, Greco, Maria Raffaella, Carvalho, Tiago M. A., Guizouarn, Helene, Soriani, Olivier, Di Molfetta, Daria, Tomasini, Richard, Zeeberg, Katrine, Reshkin, Stephan Joel, Cardone, Rosa Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367491/
https://www.ncbi.nlm.nih.gov/pubmed/35954400
http://dx.doi.org/10.3390/cancers14153737
_version_ 1784765822151950336
author Cannone, Stefania
Greco, Maria Raffaella
Carvalho, Tiago M. A.
Guizouarn, Helene
Soriani, Olivier
Di Molfetta, Daria
Tomasini, Richard
Zeeberg, Katrine
Reshkin, Stephan Joel
Cardone, Rosa Angela
author_facet Cannone, Stefania
Greco, Maria Raffaella
Carvalho, Tiago M. A.
Guizouarn, Helene
Soriani, Olivier
Di Molfetta, Daria
Tomasini, Richard
Zeeberg, Katrine
Reshkin, Stephan Joel
Cardone, Rosa Angela
author_sort Cannone, Stefania
collection PubMed
description SIMPLE SUMMARY: Here, we demonstrate for the first time that ECM composition cooperates with CAFs to jointly regulate/modulate the highly dynamic interactions between the CPC and CSC cell lines and establish a continuum between tumor initiation and progression in primary PDAC tumors. Altogether, these findings propose a scenario in which the ECM composition and the cellular secretome of the CAFs cooperate to jointly regulate both growth and morphology of the CPC and CSC cell lines and, by modulating the highly dynamic interactions between them, establishes a continuum between tumor initiation and progression in primary PDAC tumors. ABSTRACT: Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest of all cancers, having one of the lowest five-year survival rates. One of its hallmarks is a dense desmoplastic stroma consisting in the abnormal accumulation of extracellular matrix (ECM) components, especially Collagen I. This highly fibrotic stroma embeds the bulk cancer (parenchymal) cells (CPCs), cancer stem cells (CSCs) and the main producers of the stromal reaction, the Cancer Associated Fibroblasts (CAFs). Little is known about the role of the acellular ECM in the interplay of the CAFs with the different tumor cell types in determining their phenotypic plasticity and eventual cell fate. Methods: Here, we analyzed the role of ECM collagen I in modulating the effect of CAF-derived signals by incubating PDAC CPCs and CSCs grown on ECM mimicking early (low collagen I levels) and late (high collagen I levels) stage PDAC stroma with conditioned medium from primary cultured CAFs derived from patients with PDAC in a previously described three-dimensional (3D) organotypic model of PDAC. Results: We found that CAFs (1) reduced CPC growth while favoring CSC growth independently of the ECM; (2) increased the invasive capacity of only CPCs on the ECM mimicking the early tumor; and (3) favored vasculogenic mimicry (VM) especially of the CSCs on the ECM mimicking an early tumor. Conclusions: We conclude that the CAFs and acellular stromal components interact to modulate the tumor behaviors of the PDAC CPC and CSC cell types and drive metastatic progression by stimulating the phenotypic characteristics of each tumor cell type that contribute to metastasis.
format Online
Article
Text
id pubmed-9367491
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93674912022-08-12 Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition Cannone, Stefania Greco, Maria Raffaella Carvalho, Tiago M. A. Guizouarn, Helene Soriani, Olivier Di Molfetta, Daria Tomasini, Richard Zeeberg, Katrine Reshkin, Stephan Joel Cardone, Rosa Angela Cancers (Basel) Article SIMPLE SUMMARY: Here, we demonstrate for the first time that ECM composition cooperates with CAFs to jointly regulate/modulate the highly dynamic interactions between the CPC and CSC cell lines and establish a continuum between tumor initiation and progression in primary PDAC tumors. Altogether, these findings propose a scenario in which the ECM composition and the cellular secretome of the CAFs cooperate to jointly regulate both growth and morphology of the CPC and CSC cell lines and, by modulating the highly dynamic interactions between them, establishes a continuum between tumor initiation and progression in primary PDAC tumors. ABSTRACT: Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest of all cancers, having one of the lowest five-year survival rates. One of its hallmarks is a dense desmoplastic stroma consisting in the abnormal accumulation of extracellular matrix (ECM) components, especially Collagen I. This highly fibrotic stroma embeds the bulk cancer (parenchymal) cells (CPCs), cancer stem cells (CSCs) and the main producers of the stromal reaction, the Cancer Associated Fibroblasts (CAFs). Little is known about the role of the acellular ECM in the interplay of the CAFs with the different tumor cell types in determining their phenotypic plasticity and eventual cell fate. Methods: Here, we analyzed the role of ECM collagen I in modulating the effect of CAF-derived signals by incubating PDAC CPCs and CSCs grown on ECM mimicking early (low collagen I levels) and late (high collagen I levels) stage PDAC stroma with conditioned medium from primary cultured CAFs derived from patients with PDAC in a previously described three-dimensional (3D) organotypic model of PDAC. Results: We found that CAFs (1) reduced CPC growth while favoring CSC growth independently of the ECM; (2) increased the invasive capacity of only CPCs on the ECM mimicking the early tumor; and (3) favored vasculogenic mimicry (VM) especially of the CSCs on the ECM mimicking an early tumor. Conclusions: We conclude that the CAFs and acellular stromal components interact to modulate the tumor behaviors of the PDAC CPC and CSC cell types and drive metastatic progression by stimulating the phenotypic characteristics of each tumor cell type that contribute to metastasis. MDPI 2022-07-31 /pmc/articles/PMC9367491/ /pubmed/35954400 http://dx.doi.org/10.3390/cancers14153737 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cannone, Stefania
Greco, Maria Raffaella
Carvalho, Tiago M. A.
Guizouarn, Helene
Soriani, Olivier
Di Molfetta, Daria
Tomasini, Richard
Zeeberg, Katrine
Reshkin, Stephan Joel
Cardone, Rosa Angela
Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition
title Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition
title_full Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition
title_fullStr Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition
title_full_unstemmed Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition
title_short Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition
title_sort cancer associated fibroblast (caf) regulation of pdac parenchymal (cpc) and csc phenotypes is modulated by ecm composition
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367491/
https://www.ncbi.nlm.nih.gov/pubmed/35954400
http://dx.doi.org/10.3390/cancers14153737
work_keys_str_mv AT cannonestefania cancerassociatedfibroblastcafregulationofpdacparenchymalcpcandcscphenotypesismodulatedbyecmcomposition
AT grecomariaraffaella cancerassociatedfibroblastcafregulationofpdacparenchymalcpcandcscphenotypesismodulatedbyecmcomposition
AT carvalhotiagoma cancerassociatedfibroblastcafregulationofpdacparenchymalcpcandcscphenotypesismodulatedbyecmcomposition
AT guizouarnhelene cancerassociatedfibroblastcafregulationofpdacparenchymalcpcandcscphenotypesismodulatedbyecmcomposition
AT sorianiolivier cancerassociatedfibroblastcafregulationofpdacparenchymalcpcandcscphenotypesismodulatedbyecmcomposition
AT dimolfettadaria cancerassociatedfibroblastcafregulationofpdacparenchymalcpcandcscphenotypesismodulatedbyecmcomposition
AT tomasinirichard cancerassociatedfibroblastcafregulationofpdacparenchymalcpcandcscphenotypesismodulatedbyecmcomposition
AT zeebergkatrine cancerassociatedfibroblastcafregulationofpdacparenchymalcpcandcscphenotypesismodulatedbyecmcomposition
AT reshkinstephanjoel cancerassociatedfibroblastcafregulationofpdacparenchymalcpcandcscphenotypesismodulatedbyecmcomposition
AT cardonerosaangela cancerassociatedfibroblastcafregulationofpdacparenchymalcpcandcscphenotypesismodulatedbyecmcomposition